Published : Jun-2018
No. of Pages : 82
1 Table of Contents 2
1.1 List of Tables 4
1.2 List of Figures 5
2 Introduction 6
2.1 Central Venous Catheters Overview 6
3 Products under Development 7
3.1 Central Venous Catheters - Pipeline Products by Stage of Development 7
3.2 Central Venous Catheters - Pipeline Products by Segment 8
3.3 Central Venous Catheters - Pipeline Products by Territory 9
3.4 Central Venous Catheters - Pipeline Products by Regulatory Path 10
3.5 Central Venous Catheters - Pipeline Products by Estimated Approval Date 11
4 Central Venous Catheters - Pipeline Products under Development by Companies 12
4.1 Central Venous Catheters Companies - Pipeline Products by Stage of Development 12
4.2 Central Venous Catheters - Pipeline Products by Stage of Development 13
5 Central Venous Catheters Companies and Product Overview 14
5.1 Ash Access Technology Inc Company Overview 14
5.2 Bactiguard Holding AB Company Overview 15
5.3 Charite University Hospital of Berlin Company Overview 16
5.4 Globe Medical Tech Inc (Inactive) Company Overview 17
5.5 Infusense Corp Company Overview 18
5.6 Marvao Medical Devices Ltd Company Overview 19
5.7 Nipro Corp Company Overview 20
5.8 Pavmed Inc Company Overview 21
5.9 Protectus Medical Devices, Inc. Company Overview 22
5.10 S3V Vascular Technologies Company Overview 23
5.11 Sharklet Technologies Inc Company Overview 24
5.12 Silmag SA Company Overview 25
5.13 Silver Bullet Therapeutics, Inc. Company Overview 27
5.14 Teleflex Inc Company Overview 28
5.15 University of Illinois at Chicago Company Overview 29
5.16 University of Utah Company Overview 30
5.17 Vindica Therapeutics, Inc Company Overview 31
6 Central Venous Catheters- Recent Developments 32
6.1 Jun 01, 2018: BD Appoints John DeFord As Chief Technology Officer 32
6.2 May 22, 2018: PAVmed Announces First Quarter 2018 Financial Results 32
6.3 May 15, 2018: B. Braun Brings Its Commitment to The Safe Handling of Hazardous Drugs to ONS 2018 34
6.4 May 15, 2018: Retractable Technologies Announces Results as of March 31, 2018; Operating Loss Declined by 86.4% 35
6.5 May 11, 2018: BioCardia Reports First Quarter 2018 Financial Results And Business Highlights 36
6.6 May 11, 2018: Teleflex: Reaffirms 2018 Guidance and Provides 3-Year Financial Goals and Objectives 36
6.7 May 09, 2018: ICU Medical Announces First Quarter 2018 Results 37
6.8 May 03, 2018: BD Announces Results For 2018 Second Fiscal Quarter; Raises Fiscal 2018 Guidance 38
6.9 May 03, 2018: Teleflex Reports First Quarter 2018 Results 40
6.10 Apr 27, 2018: BD Names Three Executives to Segment Leadership Roles 42
6.11 Apr 20, 2018: Cook Medical Appoints Christina Anne Vice President of Distribution Channel Management 43
6.12 Apr 18, 2018: B. Braun Opens Five New Medical Production Facilities in Penang 44
6.13 Apr 02, 2018: Retractable Technologies Reports Results for the Year 2017 44
6.14 Mar 23, 2018: 2017 fiscal year: B. Braun increases sales and earnings, with investments of one billion euros 45
6.15 Mar 21, 2018: BioCardia Announces Fourth Quarter 2017 Financial Results 47
6.16 Mar 07, 2018: Bactiguard launches line extension to BIP CVC 48
6.17 Mar 01, 2018: ICU Medical Announces Fourth Quarter and Fiscal Year 2017 Results 48
6.18 Mar 01, 2018: Poly Medicure: Commencement of Commercial Production 49
6.19 Feb 22, 2018: Teleflex Reports Fourth Quarter and Full Year 2017 Results; Provides 2018 Guidance 49
6.20 Feb 13, 2018: Four start-ups chosen for the B. Braun Accelerator Program 52
6.21 Feb 12, 2018: Region Skane extends agreement with Bactiguard 52
6.22 Feb 06, 2018: BD Announces Results For 2018 First Fiscal Quarter; Provides Fiscal 2018 Guidance Updated For Inclusion Of Bard 53
6.23 Jan 18, 2018: B. Braun to Showcase Comprehensive Parenteral Nutrition Program, New Compounder and More at ASPEN 54
6.24 Jan 02, 2018: Teleflex Completes Previously Announced CEO Transition 55
6.25 Dec 15, 2017: B. Braun Launches Introcan Safety Deep Access IV Catheters 56
6.26 Dec 12, 2017: B. Braun establishes a subsidiary in Zambia 56
6.27 Nov 15, 2017: PAVmed Reports Third Quarter 2017 Financial Results 57
6.28 Nov 14, 2017: Retractable Technologies Announces Results as of September 30, 2017 59
6.29 Nov 14, 2017: Inserting And Removing Central Venous Catheters Cause Significant Discomfort In Cancer Patients And At Times Is Unnecessary 60
6.30 Nov 13, 2017: i360medical partners with Baptist Hospital South Florida to Launch Innovation Institute Miami 60
6.31 Nov 10, 2017: New clinical study shows fewer adverse events with Bactiguard's central venous catheter compared to a standard central venous catheter 61
6.32 Nov 10, 2017: BioCardia Reports Third Quarter 2017 Financial Results and Business Highlights 62
6.33 Nov 09, 2017: ICU Medical Announces Third Quarter 2017 Results 62
6.34 Nov 07, 2017: Dr. Ian McNiece Appointed BioCardia Chief Scientific Officer 63
6.35 Nov 02, 2017: Teleflex Reports Third Quarter 2017 Results 64
6.36 Oct 12, 2017: CAPS to Showcase Latest 503B Quality Assurance Capabilities and Expansion Plans at Health Connect Reverse Expo - Fall Hospital Pharmacy Conference 66
6.37 Oct 04, 2017: Bactiguard's Central Venous Catheters Approved in Hong Kong 66
6.38 Aug 30, 2017: Bactiguard's Central Venous Catheters Approved in India 67
6.39 Aug 23, 2017: Teleflex Awarded Group Purchasing Contract with Vizient for Non-Tunneled Central Venous Catheters 67
6.40 Aug 18, 2017: District Court Issues Final Judgment - Retractable Technologies v. Becton, Dickinson 68
6.41 Aug 14, 2017: PAVmed Reports Second Quarter 2017 Financial Results 68
6.42 Aug 14, 2017: Retractable Technologies Reports Results as of June 30, 2017 70
6.43 Aug 09, 2017: ICU Medical Announces Second Quarter 2017 Results 71
6.44 Aug 03, 2017: BD Announces Results For 2017 Third Fiscal Quarter 72
6.45 Aug 03, 2017: Teleflex Reports Second Quarter 2017 Results 73
6.46 Jul 31, 2017: Dr. Joachim Schulz joins the Management Board of B. Braun Melsungen 75
6.47 Jul 28, 2017: Indonesian Minister of Health Launches New German Pharmaceutical Factory in Karawang 75
6.48 Jun 29, 2017: Angel Catheter Pivotal Study Published in Journal of Vascular and Interventional Radiology 76
6.49 Jun 14, 2017: i360medical Announces Ray Cantwell as Chairman of the Board 77
7 Appendix 78
7.1 Methodology 78
7.2 About GlobalData 81
7.3 Contact Us 81
7.4 Disclaimer 81
1.1 List of Tables
Table 1: Central Venous Catheters - Pipeline Products by Stage of Development 8
Table 2: Central Venous Catheters - Pipeline Products by Segment 9
Table 3: Central Venous Catheters - Pipeline Products by Territory 10
Table 4: Central Venous Catheters - Pipeline Products by Regulatory Path 11
Table 5: Central Venous Catheters - Pipeline Products by Estimated Approval Date 12
Table 6: Central Venous Catheters Companies - Pipeline Products by Stage of Development 13
Table 7: Central Venous Catheters - Pipeline Products by Stage of Development 14
Table 8: Ash Access Technology Inc Pipeline Products & Ongoing Clinical Trials Overview 15
Table 9: BaxCath Impregnation System - Product Status 15
Table 10: BaxCath Impregnation System - Product Description 15
Table 11: Bactiguard Holding AB Pipeline Products & Ongoing Clinical Trials Overview 16
Table 12: Transvascular Injection Catheter - Product Status 16
Table 13: Transvascular Injection Catheter - Product Description 16
Table 14: Charite University Hospital of Berlin Pipeline Products & Ongoing Clinical Trials Overview 17
Table 15: Central Venous Permanent Catheter - Product Status 17
Table 16: Central Venous Permanent Catheter - Product Description 17
Table 17: Globe Medical Tech Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 18
Table 18: Safety IV Catheter - Product Status 18
Table 19: Safety IV Catheter - Product Description 18
Table 20: Infusense Corp Pipeline Products & Ongoing Clinical Trials Overview 19
Table 21: Infusense System - Product Status 19
Table 22: Infusense System - Product Description 19
Table 23: Marvao Medical Devices Ltd Pipeline Products & Ongoing Clinical Trials Overview 20
Table 24: NexSite 8Fr Single Lumen Central Venous Catheter - Product Status 20
Table 25: NexSite 8Fr Single Lumen Central Venous Catheter - Product Description 20
Table 26: Nipro Corp Pipeline Products & Ongoing Clinical Trials Overview 21
Table 27: Biocompatible Intravenous Catheter - Product Status 21
Table 28: Biocompatible Intravenous Catheter - Product Description 21
Table 29: Pavmed Inc Pipeline Products & Ongoing Clinical Trials Overview 22
Table 30: NextCath - Product Status 22
Table 31: NextCath - Product Description 22
Table 32: Protectus Medical Devices, Inc. Pipeline Products & Ongoing Clinical Trials Overview 23
Table 33: Safety IV Catheter - Product Status 23
Table 34: Safety IV Catheter - Product Description 23
Table 35: S3V Vascular Technologies Pipeline Products & Ongoing Clinical Trials Overview 24
Table 36: 3V AGILE - Product Status 24
Table 37: 3V AGILE - Product Description 24
Table 38: Sharklet Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 25
Table 39: Sharklet Central Venous Catheter - Product Status 25
Table 40: Sharklet Central Venous Catheter - Product Description 25
Table 41: Silmag SA Pipeline Products & Ongoing Clinical Trials Overview 26
Table 42: Umbilical Artery Catheter - Product Status 26
Table 43: Umbilical Artery Catheter - Product Description 26
Table 44: Umbilical Vein Catheter - Product Status 27
Table 45: Umbilical Vein Catheter - Product Description 27
Table 46: Silver Bullet Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 28
Table 47: Cathanic Venous Catheter - Product Status 28
Table 48: Cathanic Venous Catheter - Product Description 28
Table 49: Teleflex Inc Pipeline Products & Ongoing Clinical Trials Overview 29
Table 50: ARROW JACC Nurse Insertion CVC System - Product Status 29
Table 51: ARROW JACC Nurse Insertion CVC System - Product Description 29
Table 52: University of Illinois at Chicago Pipeline Products & Ongoing Clinical Trials Overview 30
Table 53: Extendable Intravenous Catheter - Product Status 30
Table 54: Extendable Intravenous Catheter - Product Description 30
Table 55: University of Utah Pipeline Products & Ongoing Clinical Trials Overview 31
Table 56: WIN NIC Central Venous Catheter Introducer Kit - Product Status 31
Table 57: WIN NIC Central Venous Catheter Introducer Kit - Product Description 31
Table 58: Vindica Therapeutics, Inc Pipeline Products & Ongoing Clinical Trials Overview 32
Table 59: Anti-Thrombotic And Anti-Infective Central Venous Catheter - Product Status 32
Table 60: Anti-Thrombotic And Anti-Infective Central Venous Catheter - Product Description 32
Table 61: Glossary 81
1.2 List of Figures
Figure 1: Central Venous Catheters - Pipeline Products by Stage of Development 8
Figure 2: Central Venous Catheters - Pipeline Products by Segment 9
Figure 3: Central Venous Catheters - Pipeline Products by Territory 10
Figure 4: Central Venous Catheters - Pipeline Products by Regulatory Path 11
Figure 5: Central Venous Catheters - Pipeline Products by Estimated Approval Date 12
